Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raya Saba

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Case Reports in Hematology|May 1, 2014
Pancytopenia in a 70-year-old african-american male: an unusual presentation of a rare diseaseAibek E Mirrakhimov, Alaa M Ali, Aram Barbaryan, et al.
Rare Tumors|July 27, 2013
Primary diffuse large B-cell lymphoma of the ascending colonAram Barbaryan, Alaa M Ali, Shawn G Kwatra, et al.
Case Reports in Hematology|May 28, 2013
Ibuprofen-induced hemolytic anemiaAram Barbaryan, Chioma Iyinagoro, Nwabundo Nwankwo, et al.
Case Reports in Oncology|March 8, 2013
Left inguinal adenopathy two years after cytoreductive surgery: a rare sign of recurrenceAibek E Mirrakhimov, Nwabundo Nwankwo, Aram Barbaryan, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2018
Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment RegimenNirav N Shah, Aniko Szabo, Raya Saba, et al.
Blood Cancer Discovery|June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome ProgressionAndrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
American Journal of Hematology|January 11, 2023
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphomaSanjal H Desai, Michael A Spinner, Kevin David, et al.
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Blood Cancer Journal|June 24, 2026
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphomaSanjal H Desai, Susan M Geyer, Levi Pederson, et al.
Blood Advances|September 20, 2023
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent eraSanjal H Desai, Michael A Spinner, Andrew M Evens, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Case Reports in Hematology|May 1, 2014
Pancytopenia in a 70-year-old african-american male: an unusual presentation of a rare diseaseAibek E Mirrakhimov, Alaa M Ali, Aram Barbaryan, et al.
Rare Tumors|July 27, 2013
Primary diffuse large B-cell lymphoma of the ascending colonAram Barbaryan, Alaa M Ali, Shawn G Kwatra, et al.
Case Reports in Hematology|May 28, 2013
Ibuprofen-induced hemolytic anemiaAram Barbaryan, Chioma Iyinagoro, Nwabundo Nwankwo, et al.
Case Reports in Oncology|March 8, 2013
Left inguinal adenopathy two years after cytoreductive surgery: a rare sign of recurrenceAibek E Mirrakhimov, Nwabundo Nwankwo, Aram Barbaryan, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2018
Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment RegimenNirav N Shah, Aniko Szabo, Raya Saba, et al.
Blood Cancer Discovery|June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome ProgressionAndrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
American Journal of Hematology|January 11, 2023
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphomaSanjal H Desai, Michael A Spinner, Kevin David, et al.
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Blood Cancer Journal|June 24, 2026
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphomaSanjal H Desai, Susan M Geyer, Levi Pederson, et al.
Blood Advances|September 20, 2023
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent eraSanjal H Desai, Michael A Spinner, Andrew M Evens, et al.
Pageof 4